Ledger.Open graph →
SEC Form D · filed January 22, 2018

MPX Bioceutical Corp

Offering
$2.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
TORONTO, Ontario, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Richard S. Segerblom · Toronto, Ontario, CanadaDirectorW. S. Boyes · Toronto, Ontario, CanadaExec · DirectorElizabeth M. Stavola · Toronto, Ontario, CanadaExec · DirectorDavid S. Mclaren · Toronto, Ontario, CanadaExecRandall G. Stafford · Toronto, Ontario, CanadaDirectorRobert R. Galvin · Cincinnati, OHDirectorAndrew R. Ryan · Toronto, Ontario, CanadaDirectorMiles D. Thompson · Toronto, Ontario, CanadaDirectorJeremy S. Budd · Toronto, Ontario, CanadaExecDavid S. Mclaren · Toronto, Ontario, CanadaExecRandall G. Stafford · Toronto, Ontario, CanadaDirectorRobert R. Galvin · Toronto, Ontario, CanadaDirectorRichard S. Segerblom · Toronto, Ontario, CanadaDirectorW. S. Boyes · Toronto, Ontario, CanadaExec · DirectorElizabeth M. Stavola · Toronto, Ontario, CanadaExec · DirectorAndrew R. Ryan · Toronto, Ontario, CanadaDirectorMiles D. Thompson · Toronto, Ontario, CanadaDirectorJeremy S. Budd · Toronto, Ontario, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗